This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
MetLife (MET) Eyes ESG Investment Manager AIM Acquisition
by Zacks Equity Research
The AIM acquisition will likely advance MetLife's (MET) capabilities to deliver long-term risk-adjusted returns to clients while enhancing ESG investment and reporting portfolio.
Should You Invest in the iShares U.S. Insurance ETF (IAK)?
by Zacks Equity Research
Sector ETF report for IAK
Zacks Industry Outlook Highlights MetLife, American International, The Hartford Financial Services, Assurant and Radian Group
by Zacks Equity Research
MetLife, American International, The Hartford Financial Services, Assurant and Radian Group are part of Zacks Industry Outlook article.
MetLife (MET) Q2 Earnings Beat on Strong Latin America Unit
by Zacks Equity Research
MetLife's (MET) adjusted net investment income declines on reduced variable investment income, stemming from decreased private equity returns.
5 Multiline Insurers to Watch as Exposure Increases, Price Rises
by Tanuka De
Better pricing, product redesigns, technological advancement along with optimistic growth outlook are expected to aid multiline insurers like MET, AIG, HIG, AIZ and RDN as the impact of the pandemic recedes.
MetLife (MET) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of 29.03% and 10.69%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Prudential (PRU) Lags Q2 Earnings Estimates
by Zacks Equity Research
Prudential (PRU) delivered earnings and revenue surprises of -33.59% and 9.69%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
MetLife (MET) to Announce Q2 Earnings: Here's What to Expect?
by Zacks Equity Research
MetLife's (MET) second-quarter results are likely to reflect increased premiums and improved profits in Latin America.
Insurance Stocks' Q2 Earnings Due on Aug 3: MET, ALL & More
by Kaibalya Pravo Dey
Interest rate hikes and favorable renewals in Q2 are likely to have aided the insurance stock results, offset by rising costs. MET, ALL, SLF, AFG & LNC are set to report earnings performance on Aug 3.
Earnings Preview: American International Group (AIG) Q2 Earnings Expected to Decline
by Zacks Equity Research
American International Group (AIG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
South State (SSB) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
South State (SSB) delivered earnings and revenue surprises of 5.88% and 5.29%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: MetLife (MET) Q2 Earnings Expected to Decline
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can MetLife (MET) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
MetLife (MET) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Regional Management (RM) Taps Indiana, Grows Base to 15th State
by Zacks Equity Research
With the expansion in Indiana, people with limited access to consumer credit are expected to benefit from Regional Management's (RM) secured credit products.
Here's Why You Should Add MetLife (MET) to Your Portfolio Now
by Zacks Equity Research
MetLife (MET) continues to benefit on the back of strong VII driving its margins, varied product launches, direct expense ratio below its targeted level and a strong cash position.
Is MetLife (MET) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Owl Rock Capital's (ORCC) Portfolio Company Acquires Liberty
by Zacks Equity Research
Owl Rock Capital (ORCC) expects the acquisition to create a premier equipment finance platform, which will be responsible for providing tailored financial solutions for the clients.
Why You Must Add American International (AIG) to Your Portfolio
by Zacks Equity Research
American International (AIG) is likely to buy back $3.9 billion of common shares by 2022 end.
Has BB Seguridade Participacoes (BBSEY) Outpaced Other Finance Stocks This Year?
by Zacks Equity Research
Here is how BB Seguridade Participacoes SA (BBSEY) and MetLife (MET) have performed compared to their sector so far this year.
The Zacks Analyst Blog Highlights W. R. Berkley, Cincinnati Financial, American Financial Group, RLI and MetLife
by Zacks Equity Research
W. R. Berkley, Cincinnati Financial, American Financial Group, RLI and MetLife have been included in this Analyst Blog.
Top 5 Insurance Stocks to Play a Higher Interest Rate Regime
by Nalak Das
We have narrowed our search to five U.S.-based insurers. These are: WRB, RLI, AFG, MET and CINF.
Assurant (AIZ) Rallies 15% YTD: Can It Retain the Momentum?
by Zacks Equity Research
The well-performing Global Lifestyle business, growth in fee-based capital-light businesses and solid capital management continue to drive Assurant (AIZ).
Is MetLife (MET) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should You Retain Brighthouse (BHF) Stock in Your Portfolio?
by Zacks Equity Research
Brighthouse (BHF) is well poised for growth on the back of higher underwriting margin, strong annuity sales, lower expenses and prudent capital deployment.
Reasons to Hold Trupanion (TRUP) Stock in Your Portfolio Now
by Zacks Equity Research
Trupanion (TRUP) is poised to grow on a change in the attitude of pet owners who are focusing on pets' health and well-being in an underpenetrated pet insurance market, product launches and extended operating boundaries.